Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-136301
Filing Date
2020-05-07
Accepted
2020-05-07 16:22:14
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d882270d10q.htm 10-Q 791923
2 EX-10.1 d882270dex101.htm EX-10.1 508509
3 EX-10.2 d882270dex102.htm EX-10.2 63607
4 EX-31.1 d882270dex311.htm EX-31.1 11037
5 EX-31.2 d882270dex312.htm EX-31.2 11109
6 EX-32.1 d882270dex321.htm EX-32.1 6345
  Complete submission text file 0001193125-20-136301.txt   3827213

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT chma-20200331.xml EX-101.INS 617292
8 XBRL TAXONOMY EXTENSION SCHEMA chma-20200331.xsd EX-101.SCH 30404
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chma-20200331_cal.xml EX-101.CAL 29434
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chma-20200331_def.xml EX-101.DEF 88868
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE chma-20200331_lab.xml EX-101.LAB 248181
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chma-20200331_pre.xml EX-101.PRE 180333
Mailing Address 460 TOTTEN POND ROAD SUITE 530 WALTHAM MA 02451
Business Address 460 TOTTEN POND ROAD SUITE 530 WALTHAM MA 02451 617-928-5300
CHIASMA, INC (Filer) CIK: 0001339469 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37500 | Film No.: 20856798
SIC: 2834 Pharmaceutical Preparations